Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $3,167,277.20 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director J. Robert Kerrey sold 12,010 shares of the business’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the sale, the director directly owned 4,794 shares in the company, valued at approximately $1,264,273.68. The trade was a 71.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tenet Healthcare Price Performance

Shares of NYSE THC traded up $4.71 during mid-day trading on Wednesday, hitting $265.56. 628,981 shares of the stock traded hands, compared to its average volume of 705,306. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $283.05. The firm has a 50 day simple moving average of $248.41 and a two-hundred day simple moving average of $212.79. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company has a market cap of $21.38 billion, a PE ratio of 10.24, a price-to-earnings-growth ratio of 0.99 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities research analysts forecast that Tenet Healthcare Corporation will post 21.04 EPS for the current fiscal year.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong analyst and quantitative support: Zacks highlighted Tenet among hospital operators benefiting from steady healthcare demand and improved efficiency. THC was also added to Zacks’ Rank #1 “Strong Buy” lists for both growth and value stocks, reinforcing the view that its earnings outlook and valuation remain attractive. 3 Hospital Stocks Riding Strong Demand and Improved Efficiency Best Growth Stocks to Buy for September 16th Best Value Stocks to Buy for September 16th
• Positive Sentiment: Potential undervaluation and earnings momentum: Zacks’ latest analysis points to favorable value, growth and momentum characteristics. That view is supported by Tenet’s latest quarterly results, which exceeded earnings and revenue estimates, with revenue increasing year over year. Are Investors Undervaluing Tenet Healthcare
• Positive Sentiment: Ambulatory strategy remains a strength: Coverage of United Surgical Partners International, Tenet’s ambulatory surgery platform, keeps attention on outpatient care, an area that can support more efficient growth and portfolio optimization. Tenet’s full-year 2026 EPS guidance and predominantly positive analyst ratings also support the bullish case. 5 Things to Know About United Surgical Partners International
• Neutral Sentiment: Restructuring creates mixed implications: Tenet’s $2.7 billion Conifer breakup is reportedly leading to 1,037 job cuts. The separation could streamline operations and sharpen strategic focus, but the near-term workforce reduction highlights execution and restructuring risks. Tenet’s $2.7B Conifer Breakup Triggers 1,037 Job Cuts
• Negative Sentiment: Director stock sale: Director Richard Mark sold 10,000 THC shares for approximately $2.6 million, reducing his position by 28.47%. The transaction is relatively small compared with Tenet’s market value but may weigh modestly on sentiment because it represents insider selling. Richard Mark Sells 10,000 Shares of Tenet Healthcare

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently added to or reduced their stakes in the business. Talon Private Wealth LLC grew its position in shares of Tenet Healthcare by 35.4% during the 2nd quarter. Talon Private Wealth LLC now owns 23,097 shares of the company’s stock worth $4,321,000 after buying an additional 6,044 shares during the period. Sequoia Financial Advisors LLC grew its holdings in Tenet Healthcare by 54.5% in the second quarter. Sequoia Financial Advisors LLC now owns 2,312 shares of the company’s stock worth $433,000 after purchasing an additional 816 shares during the period. Tidal Investments LLC increased its stake in Tenet Healthcare by 0.6% in the second quarter. Tidal Investments LLC now owns 13,296 shares of the company’s stock valued at $2,487,000 after purchasing an additional 79 shares in the last quarter. WINTON GROUP Ltd boosted its position in shares of Tenet Healthcare by 129.4% during the 2nd quarter. WINTON GROUP Ltd now owns 3,900 shares of the company’s stock worth $730,000 after purchasing an additional 2,200 shares in the last quarter. Finally, Integrated Wealth Concepts LLC grew its stake in shares of Tenet Healthcare by 49.4% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 6,276 shares of the company’s stock valued at $1,174,000 after buying an additional 2,074 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on THC. Truist Financial increased their price objective on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. Stephens reissued an “overweight” rating and issued a $285.00 price target on shares of Tenet Healthcare in a research note on Monday, July 27th. TD Cowen lifted their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Barclays increased their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Finally, Piper Sandler set a $308.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $275.53.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.